Primary Pulmonary Hypertension
Did an Unsafe Drug Cause Your Disabling Illness?
At The Callahan Law Firm in Houston, TX, our PPH attorneys recently took action on behalf of a person we believe developed primary pulmonary hypertension (PPH) due to use of a diet drug similar to Fen-Phen. Fen-Phen was taken off the market in 1997, but many credible medical experts have voiced opinions that such harmful diet drugs’ health impacts may not surface until a decade or longer after the patient has stopped using them.
If you have a serious health condition caused by a dangerous drug, contact us today to discuss whether legal action may be appropriate. Our Houston-based lawyers know primary pulmonary hypertension — also called primary arterial hypertension (PAH) — is life-altering and potentially fatal. We are dedicated to helping clients recover just, much-needed compensation from pharmaceutical companies and increasing public awareness of such risks.
Our Houston-Area Lawyers Will Assess Your Case and Legal Options
If you have primary pulmonary hypertension, you may be coping with:
- A range of limiting and disabling symptoms such as difficulty breathing and extreme fatigue
- The prospect or burden of overwhelming medical costs for ongoing treatment with drugs, a potential lung transplant, or new, experimental treatments
- The rare lung disorder PPH/PAH is called “primary” pulmonary hypertension when the cause cannot be identified. When a similar rise in blood pressure occurs because of another illness, the problem is labeled “secondary.” However, many medical opinions including a landmark Mayo Clinic study have linked Fen-Phen to primary pulmonary hypertension — and other diet drugs have similar ingredients, including ephedra.
In 1999, the manufacturer of Fen-Phen agreed to pay a multibillion-dollar settlement to victims of heart valve disease. This settlement did not eliminate future recourse for primary pulmonary hypertension sufferers, however.